Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case

Immune checkpoint inhibitors have already proved their effectiveness in the treatment of various forms of cancer, and every day their use is becoming more and more prevalent. Unfortunately, every effective treatment has its side effects, and immunotherapy is no exception. In this article, the autho...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Valančius, I. Zagorskienė, A. Klimašauskienė
Format: Article
Language:English
Published: Vilnius University Press 2021-12-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/27611
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593120964902912
author D. Valančius
I. Zagorskienė
A. Klimašauskienė
author_facet D. Valančius
I. Zagorskienė
A. Klimašauskienė
author_sort D. Valančius
collection DOAJ
description Immune checkpoint inhibitors have already proved their effectiveness in the treatment of various forms of cancer, and every day their use is becoming more and more prevalent. Unfortunately, every effective treatment has its side effects, and immunotherapy is no exception. In this article, the authors present an illustrative and rare clinical case of a patient who developed autoimmune pancerebellitis during therapy with immune checkpoint inhibitors.
format Article
id doaj-art-b4914929c3d04feeb3de804812c70187
institution Kabale University
issn 1392-3064
2424-5917
language English
publishDate 2021-12-01
publisher Vilnius University Press
record_format Article
series Neurologijos seminarai
spelling doaj-art-b4914929c3d04feeb3de804812c701872025-01-20T18:22:17ZengVilnius University PressNeurologijos seminarai1392-30642424-59172021-12-01254(90)10.29014/ns.2021.33Autoimmune pancerebellitis as an immune-related adverse event: an illustrative caseD. Valančius 0I. Zagorskienė 1A. Klimašauskienė 2Vilnius University, LithuaniaVilnius University, LithuaniaVilnius University, Lithuania Immune checkpoint inhibitors have already proved their effectiveness in the treatment of various forms of cancer, and every day their use is becoming more and more prevalent. Unfortunately, every effective treatment has its side effects, and immunotherapy is no exception. In this article, the authors present an illustrative and rare clinical case of a patient who developed autoimmune pancerebellitis during therapy with immune checkpoint inhibitors. https://www.journals.vu.lt/neurologijos_seminarai/article/view/27611immune checkpoint inhibitorsautoimmune encephalitisautoimmune pancerebellitis
spellingShingle D. Valančius
I. Zagorskienė
A. Klimašauskienė
Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
Neurologijos seminarai
immune checkpoint inhibitors
autoimmune encephalitis
autoimmune pancerebellitis
title Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
title_full Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
title_fullStr Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
title_full_unstemmed Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
title_short Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
title_sort autoimmune pancerebellitis as an immune related adverse event an illustrative case
topic immune checkpoint inhibitors
autoimmune encephalitis
autoimmune pancerebellitis
url https://www.journals.vu.lt/neurologijos_seminarai/article/view/27611
work_keys_str_mv AT dvalancius autoimmunepancerebellitisasanimmunerelatedadverseeventanillustrativecase
AT izagorskiene autoimmunepancerebellitisasanimmunerelatedadverseeventanillustrativecase
AT aklimasauskiene autoimmunepancerebellitisasanimmunerelatedadverseeventanillustrativecase